Table 1 |
|||
| Clinicopathological features of patients with OSCs | |||
| Low-grade | High-grade | P | |
| (n = 11) | (n = 70) | ||
| Age at diagnosis, yrs, median (min-max) | 52 (44–71) | 63.5 (37–89) | 0.028* |
| FIGO stage, n (%) | |||
| I-II | 4 (36.4) | 6 (8.6) | 0.026† |
| III-IV | 7 (63.6) | 64 (91.5) | |
| Mitotic activity, median (min-max) | 9 (1–12) | 27 (13–65) | < 0.001* |
| Vascular invasion, n (%) | |||
| No | 10 (90.9) | 20 (28.6) | < 0.001† |
| Yes | 1 (9.1) | 50 (71.4) | |
| Residual tumor, n (%) | |||
| No | 7 (63.6) | 12 (17.1) | 0.019† |
| ≤ 2 cm | 1 (9.1) | 14 (20.2) | |
| ≥ 2 cm | 3 (27.3) | 44 (62.9) | |
*Based on Mann–Whitney U test.
† Based on χ2 test.
Sundov et al. Diagnostic Pathology 2013 8:21 doi:10.1186/1746-1596-8-21
